calculi/protease

The link is saved to the clipboard

ArticlesClinical trialsPatents

Choose sort type

Page 1 from 17 results

Protease inhibitor-induced urolithiasis.

Only registered users can translate articles

OBJECTIVE To describe protease inhibitor-induced urinary stone disease in patients with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) who are taking indinavir sulfate (Crixivan), a protease inhibitor, for the treatment of AIDS. METHODS Patients with HIV/AIDS and

Imaging characteristics of indinavir calculi.

Only registered users can translate articles

OBJECTIVE Indinavir sulfate is an effective protease inhibitor of the human immunodeficiency virus type 1. Use is associated with a significant incidence of crystallization and stone formation in the urinary tract, and these calculi are not visible on plain radiographs. Previously all urinary

Comparison of two antiretroviral triple combinations including the protease inhibitor indinavir in children infected with human immunodeficiency virus.

Only registered users can translate articles

OBJECTIVE The effects of two antiretroviral triple combinations including the protease inhibitor indinavir on the surrogate markers, viral load and CD4 cells were evaluated. METHODS Fifteen patients with high viral load or disease progression under their prior antiretroviral therapy were switched to

[Renal colic and lithiasis in HIV(+)-patients treated with protease inhibitors].

Only registered users can translate articles

BACKGROUND Protease inhibitors, mainly Indinavir, are widely used drugs for the treatment of patients infected by the human immunodeficiency virus (HIV) and are related to renal colic and urinary obstruction. These conditions are the result of urine excretion of these drugs which favours the

[Urinary calculi and crystalluria in HIV+ patients treated with indinavir sulfate].

Only registered users can translate articles

OBJECTIVE Anti-proteases, a new class of anti-HIV drugs used in combination with reverse transcriptase inhibitors have led to spectacular improvement in the patients' clinical status. Since April 1996, indinavir is the most widely prescribed anti-protease in France. METHODS From July 1996 to July

Acute pancreatitis caused by extracorporeal shock wave lithotripsy for bilateral renal pelvic calculi.

Only registered users can translate articles

An elderly woman with a history of cholecystectomy and a re-operation for postoperative peritonitis underwent extracorporeal shock wave lithotripsy (ESWL) for right and left renal pelvic calculi, 11 x 6 and 12 x 5 mm in size, to which 2400 and 1400 shots at 20 kV were given, respectively, on the

[Influence of drugs on urological diseases].

Only registered users can translate articles

A number of drugs prescribed for the treatment of various diseases can induce urological symptoms as side effects. Antihypertensive drugs (particularly alpha blockers) can result in stress incontinence, whereas selective serotonin reuptake inhibitors (SSRI) can cause urge incontinence and estrogen

[Urinary lithiasis secondary to indinavir in an HIV-positive patient].

Only registered users can translate articles

OBJECTIVE Indinavir is a protease inhibitor used in the treatment of HIV with a lithogenic capacity as a urological side effect. The pathogenesis, diagnosis and treatment of indinavir urolithiasis are briefly reviewed. METHODS A 37-year-old male, seropositive for HIV on treatment with indinavir,

Recurrent nephrolithiasis associated with atazanavir use.

Only registered users can translate articles

A 64-year-old man with HIV on antiretroviral therapy (including atazanavir, a protease inhibitor) presented with left flank pain, nausea and vomiting. A kidney stone was suspected, and a CT scan demonstrated left hydronephrosis but failed to demonstrate nephrolithiasis or extrinsic compression. The

[Renal lithiasis due to indinavir].

Only registered users can translate articles

Indinavir sulphate is a protease inhibitor that has been found to be extremely effective in increasing CD4+ cell counts and in decreasing HIV-RNA titers in patients with HIV and AIDS. However, patients receiving indinavir also have been noted to have a significant risk of developing urolithiasis.

Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy.

Only registered users can translate articles

OBJECTIVE We describe the unique CT features of ureteric calculi in six HIV-infected patients receiving indinavir, the most commonly used HIV protease inhibitor, which is associated with an increased incidence of urolithiasis. CONCLUSIONS Ureteric obstruction caused by precipitated indinavir

Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir.

Only registered users can translate articles

Indinavir is a potent protease inhibitor widely used in combination with reverse-transcriptase inhibitors to treat human immunodeficiency virus (HIV) disease. Individuals treated with indinavir are prone to develop urinary complications, including renal colic, renal calculi, lower urinary tract

HIV medication-based urolithiasis.

Only registered users can translate articles

Drug-induced renal calculi represent 1-2% of all renal calculi. In the last decade, drugs used for the treatment of HIV-infected patients have become the most frequent cause of drug-containing urinary calculi. Among these agents, protease inhibitors (PIs) are well known to induce kidney stones,

[Indinavir and renal lithiasis].

Only registered users can translate articles

Indinavir is a new specific and potent drug that inhibits, like other antiretroviral agents, the protease of immune deficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), an enzyme necessary to maduration and replication of the virus. Indinavir has the capacity to bind the active site

Tropical pancreatitis.

Only registered users can translate articles

Tropical pancreatitis is a special type of chronic pancreatitis that is seen mainly in tropical countries. The prevalence of tropical pancreatitis is about 126/100,000 population in southern India. It occurs usually in young people, involves the main pancreatic duct and results in large ductal

Join our facebook page

Herbal & Natural Medicine

The most complete medicinal herbs database backed by science

Works in 55 languages
Herbal cures backed by science
Herbs recognition by image
Interactive GPS map - tag herbs on location (coming soon)
Read scientific publications related to your search
Search medicinal herbs by their effects
Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research